642 related articles for article (PubMed ID: 10798677)
1. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.
Wong CG; Rich KA; Liaw LH; Hsu HT; Berns MW
Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391
[TBL] [Abstract][Full Text] [Related]
3. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis.
Metrikin DC; Wilson CA; Berkowitz BA; Lam MK; Wood GK; Peshock RM
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1361-70. PubMed ID: 7775114
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.
Ozaki H; Hayashi H; Vinores SA; Moromizato Y; Campochiaro PA; Oshima K
Exp Eye Res; 1997 Apr; 64(4):505-17. PubMed ID: 9227268
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
6. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
7. Rabbit retinal neovascularization induced by latex angiogenic-derived fraction: an experimental model.
Sampaio RB; Mendonca RJ; Simioni AR; Costa RA; Siqueira RC; Correa VM; Tedesco AC; Haddad A; Coutinho Netto J; Jorge R
Curr Eye Res; 2010 Jan; 35(1):56-62. PubMed ID: 20021255
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
10. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
[TBL] [Abstract][Full Text] [Related]
12. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
13. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI.
Berkowitz BA; Tofts PS; Sen HA; Ando N; de Juan E
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3500-6. PubMed ID: 1464496
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
15. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
16. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
Berkowitz BA; Sato Y; Wilson CA; de Juan E
Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
[TBL] [Abstract][Full Text] [Related]
17. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
19. Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds.
Erb MH; Sioulis CE; Kuppermann BD; Osann K; Wong CG
Curr Eye Res; 2002 Apr; 24(4):245-52. PubMed ID: 12324862
[TBL] [Abstract][Full Text] [Related]
20. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
